{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:27:29Z","timestamp":1768710449026,"version":"3.49.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CHDDT"],"published-print":{"date-parts":[[2008,6,1]]},"DOI":"10.2174\/187152908784533685","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T06:41:36Z","timestamp":1212475296000},"page":"127-132","source":"Crossref","is-referenced-by-count":10,"title":["Torasemide for the Treatment of Heart Failure"],"prefix":"10.2174","volume":"8","author":[{"given":"Hirotaka","family":"Ishido","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Senzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Cardiovascular &amp; Hematological Disorders-Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/67031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T09:54:26Z","timestamp":1448272466000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1871-529X&volume=8&issue=2&spage=127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,1]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/187152908784533685","relation":{},"ISSN":["1871-529X"],"issn-type":[{"value":"1871-529X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6,1]]}}}